Related Experiment Video
Updated: Mar 12, 2026

09:28
Author Spotlight: Advancing EVtrap for High-Throughput Proteomics in Disease Biomarker Discovery
Published on: October 27, 2023
3.7K
Small extracellular vesicles in clinical Cancer research - A quantitative proteomics perspective.
Divya Pandey1, Vineeta Tiwari2, Dipanjana Ghosh2
1Department of Pharmaceutical Sciences, School of Health Sciences and Technology, UPES, Dehradun 248007, Uttarakhand, India; School of Pharmacy, Graphic Era Hill University, Dehradun 248002, India.
Journal of Proteomics
|March 10, 2026
Summary
Small extracellular vesicles (sEVs) are key to cell communication and cancer. Proteomics reveals sEV protein signatures in bodily fluids, offering potential for non-invasive cancer diagnostics and precision care.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Small extracellular vesicles (sEVs) are nanosized vesicles involved in intercellular communication.
- sEVs carry proteins, lipids, and nucleic acids, circulating in body fluids like blood, urine, and saliva.
- Their cargo can reflect the physiological state of the parent cell, making them promising diagnostic tools.
Purpose of the Study:
- To explore the potential of sEVs as biomarkers for cancer detection.
- To identify conserved protein signatures within sEVs across different cancer types and sample sources.
- To highlight the utility of non-invasive bodily fluids like urine and saliva for sEV-based diagnostics.
Main Methods:
- High-throughput quantitative proteomics was employed to characterize sEV protein content.
- Analysis of sEV protein profiles from various human bodily fluids, including serum, urine, and saliva.
- Cross-cancer type and cross-sample source comparison of identified protein markers.
Main Results:
- Multiple protein markers associated with inflammation, cell adhesion, immunity, and lipoprotein regulation were identified in sEVs.
- A conserved set of proteins (e.g., APOA4, SAA4, ITIH4, SERPINC1, VWF) were consistently detected across diverse cancer types and sample sources.
- These findings suggest a shared "oncogenic signature" transferable via sEVs.
Conclusions:
- sEVs represent a significant tool for advancing precision cancer care.
- The identified sEV protein signatures hold potential for early cancer diagnosis and therapy monitoring.
- Urine and saliva are promising, yet underexplored, sample sources for non-invasive sEV-based cancer diagnostics.

